Publications by authors named "Ru-Fong Cheng"

Claim this Profile
W
Women's Unique Health Needs and the Sustainable Development Goals: A Meeting Report from the 79th United Nations General Assembly Science Summit.
Irene O Aninye, Sarah Chew, Nicole Althaus, Michele Barry, Ru-Fong Cheng

J Womens Health (Larchmt)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale characterization of gender differences in diagnosis prevalence and time to diagnosis.
Tony Yue Sun, Jill Hardin, Harry Reyes Nieva, Karthik Natarajan, Ru-Fong Cheng

medRxiv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Jersey maternal mortality dashboard: an interactive social-determinants-of-health tool.
Juana A Hutchinson-Colas, Adrian Balica, Frank A Chervenak, Douglas Friedman, Linda Sloan Locke, Ru-Fong Joanne Cheng

J Perinat Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Cross-Sectional Study Evaluating the Attitudes towards a COVID-19 Vaccine in Pregnant and Postpartum Women.
Natalie D Hernandez, Sally Pairman, Alan C Fisher, Ru-Fong J Cheng, Shirley Sylvester

Vaccines (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interest in Home Birth During the COVID-19 Pandemic: Analysis of Google Trends Data.
Ru-Fong J Cheng, Alan C Fisher, Susan C Nicholson

J Midwifery Womens Health· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Algorithm of Transvaginal Ultrasound and/or Hysterosalpingogram for Confirmation Testing at 3 Months after Essure Placement.
Michel Vleugels, Ru-Fong Cheng, Jeffrey Goldstein, Keith Bangerter, Viviane Connor

J Minim Invasive Gynecol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysis.
Anita H Clayton, Eunhee Hwang, Susan G Kornstein, Karen A Tourian, Ru-fong Cheng

Int Clin Psychopharmacol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desvenlafaxine 50 and 100 mg/d versus placebo for the treatment of major depressive disorder: a phase 4, randomized controlled trial.
Anita H Clayton, Karen A Tourian, Kristen Focht, Eunhee Hwang, Ru-Fong J Cheng

J Clin Psychiatry· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of desvenlafaxine on blood pressure in patients treated for major depressive disorder: a pooled analysis.
Michael E Thase, Rana Fayyad, Ru-Fong J Cheng, Christine J Guico-Pabia, Jonathan Sporn

Curr Med Res Opin· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
JoAnn V Pinkerton, Ginger Constantine, Eunhee Hwang, Ru-Fong J Cheng,

Menopause· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: a 1-year randomized controlled trial.
JoAnn V Pinkerton, David F Archer, Christine J Guico-Pabia, Eunhee Hwang, Ru-Fong J Cheng

Menopause· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause.
David F Archer, Joann V Pinkerton, Christine J Guico-Pabia, Eunhee Hwang, Ru-Fong J Cheng

Menopause· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of dose titration and dose tapering on the tolerability of desvenlafaxine in women with vasomotor symptoms associated with menopause.
J Christopher Gallagher, Robert A Strzinek, Ru-fong J Cheng, Militza K Ausmanas, Dorothea Astl

J Womens Health (Larchmt)· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis